AMSBIO
AMSBIO is recognized today as a leading transatlantic company contributing to the acceleration of discovery through the provision of cutting-edge life science technology, products and services for research and development in the medical, nutrition, cosmetics and energy industries.
Latest Content
Product News
High Purity Exosome Standards Enhance Research Reproducibility
AMSBIO now offers high-purity, lyophilized exosome standards to enhance reproducibility in extracellular vesicle research.
Product News
Clinically Validated Collagenase and Neutral Protease Enzymes
Amsbio launches GMP-grade enzymes for tissue dissociation, supporting stem cell and regenerative medicine workflows.
Product News
Quick Differentiation Kits for iPSC Derived Neurons
Amsbio introduces iPSC kits for rapid, scalable and reproducible neural cell differentiation, enhancing flexibility for disease modeling and drug screening.
Product News
Antibodies for Stem Cell Quality Validation
Amsbio expands antibody portfolio with new markers for precise stem cell research and quality assurance.
Product News
Exploring the Role of microRNAs in the Mechanism of Stress-Induced Anxiety
A recent study from the University of Exeter Medical School reveals that miR-483-5p plays a crucial role in reducing stress and anxiety by enhancing neuronal morphology in the amygdala.
Product News
Sensitive and Specific DUB Enzyme Assay Kits
Amsbio has launched a new range of 96-well Deubiquitinating (DUB) enzyme assay kits for high-throughput screening. The kits are designed to measure DUB enzyme activity and screen inhibitors in cell-based models and purified enzyme systems.
Product News
Heparan Sulfate Antibodies Accelerate Glycobiology Research
Amsbio provides Heparan Sulfate monoclonal antibodies, crucial tools for glycobiology research, driving advances in cancer, immunology and viral infections.
Product News
Ethically Sourced Range of Human Blood Biospecimens
AMSBIO has broadened its biofluid collection and processing capabilities, now offering a wide range of customizable human blood biospecimens.
Product News
Defined Stem Cell Media Offers Easy Transition to Clinical Manufacturing
AMSBIO has launched GMP grade StemFit® for Differentiation - a chemically defined and animal component-free formulation that enables unmatched differentiation of human Induced Pluripotent Stem (hiPS) and Embryonic Stem (hES) cells.
Product News
Ready-To-Use hiPSC-Derived Cells Help Optimize Lab Workflows
AMSBIO announces a new range of ready-to-use Human induced Pluripotent Stem Cell (hiPSC) -derived cardiomyocytes, hepatocytes and neurons.
Advertisement
